Navigation Links
New Published Study Finds Noninvasive Masimo PVI Accurately Predicts Fluid Responsiveness in Intensive Care Patients
Date:2/1/2011

IRVINE, Calif., Feb. 1, 2011 /PRNewswire/ -- Masimo (Nasdaq: MASI) announced today that a new study published in the peer-reviewed journal Critical Care Medicine demonstrates that noninvasive, continuous monitoring of Masimo Pleth Variability Index (PVI®) predicts fluid responsiveness with high sensitivity (95%) and specificity (91%) in mechanically-ventilated patients in the Intensive Care Unit (ICU).(1)   Multiple previous studies have shown that PVI predicts fluid responsiveness in surgical patients—helping clinicians improve fluid management to reduce patient risk,(2, 3, 4) but this is the first published study demonstrating its effectiveness in predicting fluid responsiveness in critically-ill ICU patients.  

Hemodynamic instability is a common problem for critically-ill patients, but the decision to administer fluid in an attempt to improve cardiac output is challenging. When necessary, fluid administration is critical to optimizing patient status and enabling end organ preservation, but unnecessary fluid administration is associated with increased morbidity and mortality.  However, other dynamic indicators for assessing intravascular fluid volume are either invasive, operator dependent, costly, or unreliable predictors of whether a patient will benefit from fluid administration.

Citing numerous prospective studies showing that "only half of critically-ill patients respond to fluid boluses deemed necessary by attending physicians," researchers from CHU de Poitiers (France) acknowledged the "need for simple, noninvasive, and continuous bedside monitoring capable of detecting fluid responsiveness early in virtually all ICU patients, including those without an arterial catheter" in undertaking the current study. PVI provides clinicians with a
'/>"/>

SOURCE Masimo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Medimetriks Pharmaceuticals, ... the second Phase III clinical study for Ozenoxacin, ... impetigo.  Medimetriks owns the exclusive U.S. rights to ... trial, conducted at 44 centers with an emphasis ... patients aged 2 months and older with a ...
(Date:7/30/2015)... Global ENT (Ear, Nose, ... USD 23.01 million in 2022, according to a new ... geriatric population, increasing prevalence of ear, nose, and throat ... among target customer base are expected serve this market ... According to estimates published by the WHO, 15% of ...
(Date:7/30/2015)... 2015  NanoSmart Pharmaceuticals, Inc., a private pharmaceutical ... Orphan Drug Designation from the Food and Drug ... uses NanoSmart,s proprietary drug delivery platform. The drug ... treatment of Ewing,s sarcoma, a rare type of ... Drug Designation on the basis of a plausible ...
Breaking Medicine Technology:Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2
... Nutri-Force Nutrition is proud to announce the ... Miami Lakes, Florida. This new facility was designed ... customers with industry-leading quality and exceptionally efficient manufacturing ... innovative production control processes, the new facility includes ...
... 10 Stryker Corporation (NYSE: SYK ) announced ... held, software technology firm. OtisMed will focus on ... many benefits that surgeons and patients realize from Stryker,s ... OtisMed will operate as part of Stryker,s Orthopaedics Division ...
Cached Medicine Technology:Stryker Announces Agreements To Acquire Assets 2Stryker Announces Agreements To Acquire Assets 3
(Date:7/30/2015)... County, CA (PRWEB) , ... July 30, 2015 ... ... home health care throughout Orange, Riverside, Los Angeles, and San Bernardino counties, today ... as the new Palliative Care Administrator. Dr. Demoratz is a strong proponent of ...
(Date:7/30/2015)... Orange County, CA (PRWEB) , ... July 30, 2015 , ... ... Orange County, Los Angeles, Riverside, and San Bernardino, recently announced that the Centers for ... a new rating system of home health care providers. 24/7 Care At Home’s agency ...
(Date:7/30/2015)... Huntington Beach, CA (PRWEB) , ... ... ... Nursing Center recently released a video, “Beachside Nursing Center,” to announce its ... satisfaction and five-star ratings. Beachside's administrator and staff members support the CMS ...
(Date:7/30/2015)... ... July 30, 2015 , ... The need for accessibility is never greater ... comfort to patients as well as visiting friends and family during these critical moments, ... , The stations - powered by ChargeItSpot , a Philadelphia-based startup that recently ...
(Date:7/30/2015)... ... 30, 2015 , ... The Beryl Institute announces its sixth ... with Patient Experience Institute, these offerings reinforce the commitment to help frame and ... throughout the experience movement, and provide information and research to support expanded focus ...
Breaking Medicine News(10 mins):Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2Health News:Beachside Nursing Center Releases New Video 2Health News:Hospitals Add Phone Charging Stations as an Amenity for Patients and Visitors 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3
... Cancer Genome Atlas (TCGA) has reported results from its ... cancer glioblastoma. , The findings are reported in the ... , The TCGA team, comprised of more than 100 ... the country, analyzed 601 genes in tumor samples from ...
... probability of someone cheating during the course of a relationship ... Genevive Beaulieu-Pelletier, PhD student at the Universit de Montral,s Department ... we get married with the best of intentions things don,t ... about infidelity is why people are willing to conduct themselves ...
... spend $1M a day sponsoring campus events, giveaways, lung ... Fewer U.S. college students (1 in 5) are smoking ... need to take a stand against aggressive tobacco industry ... a new American Lung Association report finds. , ...
... Sutter Health Partners, Wellness Program Proves Cost-Saving for Employers ... and Life-Saving for Employees, ... five months. Donna Rosenbusch, R.N., is completing triathlons. Marcia,Augsburger is seeing ... and staff at the law firm where she is a,partner. And ...
... Parents probably,wouldn,t have guessed, but kids like soyfoods. ... soyfoods as much as meat,counterparts. The trick -- ... soyfoods., A plate waste study, funded by ... macaroni & cheese, burgers, chicken nuggets, and,chicken Caesar ...
... $ 885 thousand, 400 thousand) for each of ... by the winners to research projects , Milan, 8 September ... were announced today in a public event: , ... Visual Arts since 1700, Thomas Nagel (USA), University of New ...
Cached Medicine News:Health News:The Cancer Genome Atlas reports first results, Johns Hopkins Kimmel Cancer Center collaborates 2Health News:Infidelity dissected: New research on why people cheat 2Health News:Fewer College Kids Smoking, But Industry Tactics a Threat 2Health News:Fewer College Kids Smoking, But Industry Tactics a Threat 3Health News:'Live Well for Life' Benefits Companies and Workers 2Health News:'Live Well for Life' Benefits Companies and Workers 3Health News:'Live Well for Life' Benefits Companies and Workers 4Health News:Back to School With Soy 2Health News:Balzan Foundation announced 2008 prize winners 2Health News:Balzan Foundation announced 2008 prize winners 3
Immuno-turbidimetric Assay for Protein S Antigen. Suspension of microlatex particles coated with specific antibodies....
Colorimetric Assay of Unfractionated and Low Molecular Weight Heparins by STA© Analyzers. Lyophilized, patent-pending chromogenic substate, CBS 52.44 of ~8.8 moles/vial and bovine factorXa ~2.2 ...
Substrate Plasma for Factor VII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VII has been removed by selective immuno-adsorption....
Substrate Plasma for Factor XI Assay by STA© Analyzers. Freeze-dried human plasma lacking factor XI....
Medicine Products: